Enhanced BMP-2-Mediated Bone Repair Using an Anisotropic Silk Fibroin Scaffold Coated with Bone-like Apatite.
Adenosine Triphosphate
/ metabolism
Animals
Anisotropy
Apatites
/ pharmacology
Biomimetic Materials
/ pharmacology
Bone Morphogenetic Protein 2
/ pharmacology
Bone Regeneration
/ drug effects
Bone and Bones
/ drug effects
Caspase 7
/ metabolism
Caspases
/ metabolism
Femur
/ diagnostic imaging
Fibroins
/ pharmacology
Freezing
Humans
Male
Rats, Sprague-Dawley
Recombinant Proteins
/ pharmacology
Tissue Scaffolds
/ chemistry
Transforming Growth Factor beta
/ pharmacology
X-Ray Microtomography
bone regeneration
critical sized defect
nonunion
pseudarthrosis
silk scaffold
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
28 Dec 2021
28 Dec 2021
Historique:
received:
17
11
2021
revised:
20
12
2021
accepted:
22
12
2021
entrez:
11
1
2022
pubmed:
12
1
2022
medline:
2
2
2022
Statut:
epublish
Résumé
The repair of large bone defects remains challenging and often requires graft material due to limited availability of autologous bone. In clinical settings, collagen sponges loaded with excessive amounts of bone morphogenetic protein 2 (rhBMP-2) are occasionally used for the treatment of bone non-unions, increasing the risk of adverse events. Therefore, strategies to reduce rhBMP-2 dosage are desirable. Silk scaffolds show great promise due to their favorable biocompatibility and their utility for various biofabrication methods. For this study, we generated silk scaffolds with axially aligned pores, which were subsequently treated with 10× simulated body fluid (SBF) to generate an apatitic calcium phosphate coating. Using a rat femoral critical sized defect model (CSD) we evaluated if the resulting scaffold allows the reduction of BMP-2 dosage to promote efficient bone repair by providing appropriate guidance cues. Highly porous, anisotropic silk scaffolds were produced, demonstrating good cytocompatibility in vitro and treatment with 10× SBF resulted in efficient surface coating. In vivo, the coated silk scaffolds loaded with a low dose of rhBMP-2 demonstrated significantly improved bone regeneration when compared to the unmineralized scaffold. Overall, our findings show that this simple and cost-efficient technique yields scaffolds that enhance rhBMP-2 mediated bone healing.
Identifiants
pubmed: 35008718
pii: ijms23010283
doi: 10.3390/ijms23010283
pmc: PMC8745248
pii:
doi:
Substances chimiques
Apatites
0
Bone Morphogenetic Protein 2
0
Recombinant Proteins
0
Transforming Growth Factor beta
0
recombinant human bone morphogenetic protein-2
0
Adenosine Triphosphate
8L70Q75FXE
Fibroins
9007-76-5
Caspase 7
EC 3.4.22.-
Caspases
EC 3.4.22.-
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Lorenz Böhler Gesellschaft
ID : 04/16
Références
J Cell Mol Med. 2011 Jun;15(6):1266-86
pubmed: 21251219
Bone. 2008 Jun;42(6):1226-34
pubmed: 18387349
In Vivo. 2019 Jul-Aug;33(4):1067-1079
pubmed: 31280194
Medicina (Kaunas). 2021 Jul 27;57(8):
pubmed: 34440965
J Pers Med. 2021 Aug 09;11(8):
pubmed: 34442418
J Tissue Eng Regen Med. 2017 Jul;11(7):2014-2023
pubmed: 26510918
J Mater Chem B. 2021 Jan 28;9(4):889-907
pubmed: 33331386
J Biomed Mater Res A. 2019 May;107(5):968-977
pubmed: 30684387
J Musculoskelet Neuronal Interact. 2012 Mar;12(1):28-37
pubmed: 22373949
Eur Cell Mater. 2015 Mar 04;29:141-53; discussion 153-4
pubmed: 25738583
Biomaterials. 2015 May;49:103-12
pubmed: 25725559
Nat Commun. 2018 Oct 25;9(1):4430
pubmed: 30361486
Nat Protoc. 2011 Sep 22;6(10):1612-31
pubmed: 21959241
Spine J. 2021 May;21(5):865-873
pubmed: 33493682
Anal Biochem. 1984 Feb;136(2):433-9
pubmed: 6721143
Spine (Phila Pa 1976). 2016 Jul 15;41(14):E829-E836
pubmed: 26679888
Biomaterials. 1991 Mar;12(2):155-63
pubmed: 1878450
Biomaterials. 2015 Dec;71:145-157
pubmed: 26322725
Regen Biomater. 2020 Feb;7(1):19-27
pubmed: 32440358
Eur J Med Res. 2020 Dec 21;25(1):70
pubmed: 33349266
Biomaterials. 2012 Jan;33(2):713-21
pubmed: 22014948
J Orthop Trauma. 2021 Aug 27;:
pubmed: 34483318
Int J Mol Sci. 2021 Feb 02;22(3):
pubmed: 33540895
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
J Tissue Eng Regen Med. 2019 Oct;13(10):1843-1853
pubmed: 31306563
J Control Release. 2021 Oct 10;338:571-582
pubmed: 34481026
Materials (Basel). 2021 Feb 01;14(3):
pubmed: 33535662
J Orthop Res. 2010 Feb;28(2):258-64
pubmed: 19639633
World Neurosurg. 2021 Dec;156:e64-e71
pubmed: 34530148
Int J Mol Sci. 2021 Jan 23;22(3):
pubmed: 33498786
Injury. 2008 Sep;39 Suppl 2:S45-57
pubmed: 18804573
Cochrane Database Syst Rev. 2010 Jun 16;(6):CD006950
pubmed: 20556771
Philos Trans A Math Phys Eng Sci. 2004 Dec 15;362(1825):2821-50
pubmed: 15539372
Anal Biochem. 1984 Feb;136(2):440-5
pubmed: 6721144
Adv Drug Deliv Rev. 2012 Sep;64(12):1111-22
pubmed: 22522139
Tissue Eng Part B Rev. 2016 Aug;22(4):284-97
pubmed: 26857241
Anal Biochem. 1984 Feb;136(2):425-32
pubmed: 6721142
Clin Orthop Surg. 2021 Sep;13(3):301-306
pubmed: 34484621
Biomaterials. 2010 Jan;31(3):461-6
pubmed: 19819008
Biomed Mater. 2015 Mar 31;10(3):034105
pubmed: 25826196
Biomaterials. 2013 Jan;34(2):452-9
pubmed: 23099062
Clin Orthop Relat Res. 2000 Feb;(371):10-27
pubmed: 10693546
Biomacromolecules. 2011 May 9;12(5):1686-96
pubmed: 21425769
Adv Mater. 2018 Jul;30(28):e1706754
pubmed: 29847704